MLB: Twins reinstate RHP Pablo Lopez from IL to start vs. Angels

Date:

Share post:


The Minnesota Twins activated right-hander Pablo Lopez from the 15-day injured list to start Friday’s game against the Los Angeles Angels in Minneapolis.

Lopez was placed on the 15-day injured list April 11 with a right hamstring strain.

He threw 63 pitches in 4 2/3 innings in a rehab start with Triple-A St. Paul on Saturday. He gave up one run on three hits and struck out four without walking a batter.

“I’m feeling good, but also I got to the point where I’m still working … on sequences, hitting my spots and seeing what the training staff tells me, but everything’s moving well, feeling natural, feeling normal,” Lopez said after the start.

Lopez, 29, is 1-1 with a 1.62 ERA through three starts with the Twins, striking out 14 and walking two batters in 16 2/3 innings.

The former All-Star is 55-50 with a 3.86 ERA in 161 games (all starts) with the Miami Marlins (2018-22) and Twins.

Lopez is 3-1 with a 3.38 ERA in four career starts against the Angels. He takes the roster spot vacated by right-hander David Festa, who was optioned after his start on Wednesday night against the Chicago White Sox.

–Field Level Media

spot_img

Related articles

MLB: MLB removes Pete Rose, ‘Shoeless’ Joe Jackson from permanently ineligible list

Pete Rose and "Shoeless" Joe Jackson -- longstanding pariahs in Major League Baseball due to their gambling on...

MLB: Cardinals-Phillies postponed; twin bill set for Wednesday

The Philadelphia Phillies' game against the visiting St. Louis Cardinals on Tuesday was postponed due to rain in...

MLB: Twins-Orioles rained out; doubleheader Wednesday

The Baltimore Orioles' home game Tuesday against the Minnesota Twins was postponed due to inclement weather. Instead, the teams...

MLB: Yankees activate DJ LeMahieu, put Oswaldo Cabrera on IL

The New York Yankees reinstated infielder DJ LeMahieu from the 10-day injured list Tuesday and placed versatile Oswaldo...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.